Back

Prospective validation of a self-report-based model for coronary artery calcium screening and assessment of treatment gaps in lipid-lowering therapy.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Drug therapy (1) Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Eva Hagberg

Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

7 More presentations in this session

Presentation thumbnail
The association between the response of lipid-lowering agents and monogenic variants of familiar hypercholesteremia in Taiwan
Professor P. Liu (Tainan, TW)
Abstract Slides Video
Presentation thumbnail
BW-00112 targeting ANGPTL3 results in prolonged reductions in plasma triglycerides, LDL-C, and remnant-C in Chinese healthy subjects
Ms Y. Li (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKM
Professor M. Miller (Philadelphia, US)
Abstract Slides Video
Presentation thumbnail
PCSK-9-inhibitor therapy improves endothelial function in patients with coronary artery disease
Doctor A. Bosch (Erlangen, DE)
Abstract Slides Video
Presentation thumbnail
Effectiveness of statins for primary prevention in the elderly - a propensity score matched cohort study
Doctor D. Leibowitz (Jerusalem, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Drug therapy (1)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of early atherosclerosis imaging on risk stratification, treatment strategy, and potential clinical outcomes in a primary prevention cohort
thumbnail
Congress Presentation
Long-term follow-up of repeated patient visualization of coronary artery calcium images in intermediate risk individuals: ten-year follow-up of the CAUGHT-CAD trial
thumbnail
Congress Presentation
Preliminary results of ROCAMBOLE: pre-test probability (PTP) for coronary artery disease (CAD) is enhanced by incorporating risk factors and coronary artery calcium (CAC) score

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources